NDA 076732 describes METOLAZONE, which is a drug marketed by
Alembic,
Ani Pharms,
Bayshore Pharms Llc,
Innogenix,
Leading,
Mylan,
Ne Rx Pharma,
Renata,
Roxane,
Rubicon,
Sandoz, and
Watson Labs, and is included in thirteen NDAs. It is available from
eighteen suppliers. Additional details are available on the
METOLAZONE profile page.
The generic ingredient in METOLAZONE is
metolazone. There are ten
drug master file entries for this compound. Eighteen
suppliers are listed for this compound. Additional details are available on the
metolazone profile page.